Advances in Drug Discovery and Targeted Therapy for Alzheimer's Disease

個数:

Advances in Drug Discovery and Targeted Therapy for Alzheimer's Disease

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    【重要ご説明事項】
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 354 p.
  • 言語 ENG
  • 商品コード 9781779642677
  • DDC分類 616.8311061

Full Description

This new volume, Advances in Drug Discovery and Targeted Therapy for Alzheimer's Disease, offers a comprehensive exploration of the forefront of research and innovation in this vital area. The culmination of the collective efforts of leading academicians and researchers who are dedicated to unraveling the complexities of AD and devising targeted solutions, the volume covers novel drug targets, emerging therapeutic strategies, and the latest developments in drug discovery technologies that are shaping the future of AD treatment.

The book delves into the multifaceted nature of AD, exploring recent breakthroughs in understanding its pathophysiology and the development of targeted interventions. The book is structured into several thematic sections, each of which addresses a different facet of AD research and therapy development. Together, these sections offer a holistic view of the challenges and opportunities that researchers face as they work toward new therapeutic strategies.

The volume first covers the complex pathophysiology of AD, offering insights into the molecular and cellular mechanisms underlying the disease, presenting the latest research on classical targets such as acetylcholinesterase, monoamine oxidases, and amyloid-beta plaques. It discusses why conventional treatments have fallen short and highlights the need for new therapeutic strategies.

The volume goes on to focus on cutting-edge therapeutic approaches that are revolutionizing the field of Alzheimer's drug discovery. The Tau protein, implicated in neurofibrillary tangles, NMDA blockers for modulating excitotoxicity, CDK5 for its involvement in Tau hyperphosphorylation, and Caspases as mediators of apoptosis, are explored in detail. By addressing these nonclassical but critical targets, the focus is on how these innovations are accelerating the discovery of novel compounds with the potential to alter the course of AD.

Chapters also cover the novel mechanistic approaches leading to the development of targeted therapies that address specific aspects of AD pathology, reviewing emerging strategies such as a FAAH-ChE based multifunctional ligand strategy, which offers dual-target solutions and immunotherapy. The book also emphasizes the role of synaptogenesis in maintaining cognitive function and highlights natural products as promising neuroprotective agents. These cutting-edge strategies collectively represent the forefront of AD research, aiming to provide comprehensive and effective management solutions for this challenging condition.

Bringing together diverse expertise and perspectives that reflect the multifaceted nature of AD research, the volume provides a deep understanding of Alzheimer's drug discovery. The insights shared within these will stimulate further research and dialogue among researchers, clinicians, and pharmaceutical professionals dedicated to combating Alzheimer's disease. It will be a valuable resource for postgraduate students, research scholars, professors, researchers in the pharmaceutical and biotechnology fields, and healthcare professionals specializing in neurosciences, including Alzheimer's disease and related dementias.

Contents

Preface Introduction Part I: Classical Targets 1. Etiology, Neuropathology, and Pathogenesis of Alzheimer's Disease 2. Acetylcholinesterase as a Therapeutic Target for Alzheimer's Disease Treatment 3. Monoamine Oxidases as a Potential Target for Alzheimer's Disease 4. Beta-secretase Inhibitors as Therapies for Alzheimer's Disease: Present Situation and Future Prospects Part II: Nonclassical Targets 5. Alzheimer's Disease Treatments Targeting Tau Protein: Current Trends and Future Outlook 6. NMDA Receptor Blockers: A Cutting-Edge Weapon for Alzheimer's Disease 7. Cyclin-Dependent Kinase 5 (CDK5): An Important Target to Fight Alzheimer's Disease 8. Role of Caspases in Alzheimer's Disease Part III: Novel Mechanistic Approaches 9. FAAH-ChE-Based Multifunctional Ligand Approach: A Novel Strategy to Treat Alzheimer's Disease 10. Immunotherapy as a Novel Approach to Treat Alzheimer's Disease 11. Role of Synaptogenesis Enhancers in the Management of Alzheimer's Disease 12. Neuroprotective Role of Essential Oils in the Management of Alzheimer Disease 13. Natural Products and Their Role in the Management of Alzheimer's Disease Index

最近チェックした商品